Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma.

Clin Cancer Res · 2023 · PMC10068441 · PMID 36815791

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

only marginally significantno p-value reported

This analysis was replicated using the publically available TCGA dataset, which showed only marginally significant difference between the VHL +0 and VHL +2 groups, and no differences between the VHL +1, VHL +2, and VHL +≥3 tumors (Supplementary Table S12).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.